2021: A Record-Breaking Year For ‘Smart’ Pricing And Access Deals In England
Innovative Deals Between Pharma And The NHS Enabled Swifter Access To Treatments
NHS England and Improvement (NHSE&I) agreed 16 pricing and access deals with drug companies in 2021, ten of which can be considered ‘smart.’ The fact that these were achieved against a backdrop of COVID-19 is seen as impressive.
